PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,030,000 | -19.5% | 75,767 | -11.8% | 0.01% | -11.1% |
| Q2 2022 | $5,006,000 | -1.7% | 85,863 | +28.6% | 0.01% | +12.5% |
| Q1 2022 | $5,094,000 | -64.8% | 66,742 | -85.6% | 0.01% | -76.5% |
| Q1 2018 | $14,455,000 | -75.1% | 464,039 | -63.5% | 0.03% | -47.7% |
| Q4 2017 | $58,084,000 | +139.4% | 1,272,376 | +96.9% | 0.06% | +16.1% |
| Q3 2017 | $24,260,000 | -22.3% | 646,064 | -1.2% | 0.06% | -23.3% |
| Q2 2017 | $31,204,000 | +46.6% | 654,174 | +40.2% | 0.07% | +46.0% |
| Q1 2017 | $21,278,000 | +1806.6% | 466,616 | +1250.6% | 0.05% | +1566.7% |
| Q4 2016 | $1,116,000 | +11.9% | 34,549 | +18.6% | 0.00% | +50.0% |
| Q3 2016 | $997,000 | -64.4% | 29,139 | -64.9% | 0.00% | -71.4% |
| Q2 2016 | $2,797,000 | +27.1% | 82,911 | +99.6% | 0.01% | +40.0% |
| Q1 2016 | $2,200,000 | -61.3% | 41,534 | -44.0% | 0.01% | -61.5% |
| Q4 2015 | $5,691,000 | -8.4% | 74,119 | -50.9% | 0.01% | -7.1% |
| Q3 2015 | $6,210,000 | -54.4% | 151,100 | -21.6% | 0.01% | -48.1% |
| Q2 2015 | $13,633,000 | -11.9% | 192,762 | +10.7% | 0.03% | -12.9% |
| Q1 2015 | $15,475,000 | – | 174,170 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |